World ADC is pleased to announce the winners of the 3rd Annual World ADC Awards.

The World ADC Awards reward the innovation, leadership, and devotion shown by the best companies, teams, and individuals in the industry. Across nine categories the Awards exist to recognize the extraordinary endeavor's, teamwork and commercial acumen that has propelled the field to the forefront of cancer research today. The Awards are sponsored by Abbvie and Pfizer.

The Awardees were shortlisted by over 1500 nominations and then scientific proposals from each were evaluated by our Judging panel.

Fiona Mistri, Program Director, World ADC San Diego stated: "Every year the judges are impressed with the level of innovation and scientific breakthroughs that these companies are driving. This year is no exception and we are delighted to see the calibre and quantity of entries - showing the growing momentum and advances being made within the industry.

The 2016 winners are:

Best ADC Platform Technology
Winner - Fleximer (Mersana Therapeutics)
Runner Up - Bicycles (Bicycle Therapeutics)

Most Promising Clinical Candidate
Winner - Rovalpituzumab tesirine (Abbvie-Stemcentrx)
Runner Up - MEDI4276 (MedImmune)

Best Contract Manufacturing (CMO) Provider
Winner - BSP Pharmaceuticals
Runner Up - Piramal

Best Contract Research (CRO) Provider
Winner - Abzena

Best New Drug Developer sponsored by Pfizer
Winner - ADC Therapeutics
Runner Up - Mersana Therapeutics

Best Publication 2015
Winner - Saunders et al., A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo. Sci Transl Med., 2015.
Runner Up - van Geel et al., Chemoenzymatic Conjugation of Toxic Payloads to the Globally Conserved N-Glycan of Native mAbs Provides Homogeneous and Highly Efficacious Antibody-Drug Conjugates; Bioconj. Chem., 2015.

Best Poster sponsored by Abbvie
Winner - Computational Exploration of Mechanistic Determinants of ADC Pharmacokinetics Using QSP Modeling Strategies; AK Wilkens et al.
Runner Up - Discovery and Characterization of ADCs with a Novel Mode of Action; G Piizzi et al.

Individual Input to the Field 2015/2016
Winner - David Thurston
Runner Up - Scott Dylla

Long Standing Contribution
Winner - John Lambert

The Award winners were announced at an Awards Ceremony on October 12 at the Marriott Marquis San Diego, as part of the 7th Annual World ADC San Diego.

Scott Dylla, VP R&D and CSO, Abbvie-Stemcentrx remarked: "Support of these awards represents AbbVie's dedication to and recognition of innovation in Antibody Drug Conjugate research around the world. These awards, which acknowledge peer-recognized notable work and contributions to the ADC field are aligned with our passion for developing novel therapies to address the world's most difficult health problems and providing a remarkable impact on people's lives."

For more information about the World ADC Awards visit